CXCL8 and gastric cancer: IL-8 has been characterized to activate PI3K-Akt signaling through modulating phosphorylation/activation of Akt and S6 (MacManus et al. 2007), while PI3K-Akt-mTOR signaling was also reported to enhance IL-8 production as feedback (Lin et al. 2019), which comply with our findings in gastric cancer.